Levetiracetam | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Levetiracetam
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Levetiracetam

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

104 API Suppliers, 46 USDMF, 44 CEP/COS, 10 JDMF, 34 EU WC, 41 KDMF, 32 NDC API, 60 Listed Suppliers, $ API Reference Price

104 API Suppliers
46 USDMF
44 CEP/COS
10 JDMF
34 EU WC
41 KDMF
32 NDC API
60 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

13 Drugs in Development

13 Drugs in Development

INTERMEDIATES

22 Intermediate Suppliers

22 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1033 FDF Dossiers, 241 FDA Orange Book, 503 Europe, 58 Canada, 74 Australia, 21 South Africa, 136 Listed Dossiers

1033 FDF Dossiers
241 FDA Orange Book
503 Europe
58 Canada
74 Australia
21 South Africa
136 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 1GM, TABLET;ORAL - 250MG, TABLET;ORAL - 500MG, TABLET;ORAL - 750MG, INJECTABLE;INTRAVENOUS - 500MG/5ML (100MG/ML), TABLET, EXTENDED RELEASE;ORAL - 500MG, TABLET, EXTENDED RELEASE;ORAL - 750MG

TABLET;ORAL - 1GM
TABLET;ORAL - 250MG
TABLET;ORAL - 500MG
TABLET;ORAL - 750MG
INJECTABLE;INTRAVENOUS - 500MG/5ML (100MG/ML)
TABLET, EXTENDED RELEASE;ORAL - 500MG
TABLET, EXTENDED RELEASE;ORAL - 750MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 5 Evonik, 7 Rochem International Inc, 19 SPI Pharma, 2 Seqens, 7 DKSH, 2 Pharm-RX Chemical, 9 Faran Shimi Pharmaceutical, 12 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 13 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 15 Actylis, 2 Aeon Procare, 3 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 42 BASF, 1 Bioplus Life Sciences, 2 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 18 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 5 Novo Excipients, 4 Pharmatrans-Sanaq, 10 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 41 Roquette, 17 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

116 Fillers, Diluents & Binders, 68 Coating Systems & Additives, 46 Direct Compression, 44 Thickeners and Stabilizers, 44 Disintegrants & Superdisintegrants, 44 Taste Masking, 42 Controlled & Modified Release, 42 Film Formers & Plasticizers, 40 Solubilizers, 38 Granulation, 35 Topical, 33 Parenteral, 26 Lubricants & Glidants, 21 Chewable & Orodispersible Aids, 19 Co-Processed Excipients, 16 Emulsifying Agents, 9 Surfactant & Foaming Agents, 8 API Stability Enhancers, 7 Rheology Modifiers, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

116 Fillers, Diluents & Binders
68 Coating Systems & Additives
46 Direct Compression
44 Thickeners and Stabilizers
44 Disintegrants & Superdisintegrants
44 Taste Masking
42 Controlled & Modified Release
42 Film Formers & Plasticizers
40 Solubilizers
38 Granulation
35 Topical
33 Parenteral
26 Lubricants & Glidants
21 Chewable & Orodispersible Aids
19 Co-Processed Excipients
16 Emulsifying Agents
9 Surfactant & Foaming Agents
8 API Stability Enhancers
7 Rheology Modifiers
5 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 59 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
59 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 410 Finished Drug Prices, 11 Annual Reports

3 US Medicaid Prescriptions
410 Finished Drug Prices
11 Annual Reports

MARKET PLACE

34 APIs, 13 FDF Dossiers

34 APIs
13 FDF Dossiers

PATENTS & EXCLUSIVITIES

40 US Patents, 3 Health Canada Patents

40 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 4 USP, 10 Others

5 EDQM
4 USP
10 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 62 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 3Gowling Lafleur Henderson LLP

filter Patent Reset all filters

3 All

01 32581831

filter Product Reset all filters

3 All

01 3LEVETIRACETAM

filter Dosage Reset all filters

3 All

01 3TABLET

filter Exp Date Reset all filters

3 All

01 32026-07-24

Product Main Page

01

Gowling Lafleur Henderson LLP

Levetiracetam

The Generic Rx Session

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-07-24

Date Granted : 2013-11-12

Levetiracetam

Brand Name : KEPPRA

Patent Number : 2581831

Filing Date : 2006-07-24

Strength per Unit : 250 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-07-24

Date Granted : 2013-11-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling Lafleur Henderson LLP

Levetiracetam

The Generic Rx Session

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-07-24

Date Granted : 2013-11-12

Levetiracetam

Brand Name : KEPPRA

Patent Number : 2581831

Filing Date : 2006-07-24

Strength per Unit : 500 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-07-24

Date Granted : 2013-11-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling Lafleur Henderson LLP

Levetiracetam

The Generic Rx Session

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-07-24

Date Granted : 2013-11-12

Levetiracetam

Brand Name : KEPPRA

Patent Number : 2581831

Filing Date : 2006-07-24

Strength per Unit : 750 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-07-24

Date Granted : 2013-11-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!